Brief: Maxcyte Announces Multi-Drug Clinical & Commercial Agreement With Kite, A Gilead Company
01/03/2019 07:31
March 1 (Reuters) - MaxCyte Inc MXCT.L :
* MAXCYTE ANNOUNCES MULTI-DRUG CLINICAL & COMMERCIAL
AGREEMENT
WITH KITE, A GILEAD COMPANY
Source text for Eikon: urn:newsml:reuters.com:*:nRSA5188Ra
Further company coverage: MXCT.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsMaxCyte, Inc. MaxCyte, Inc. - MXCR - Second Price Monitoring Extn
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Price Monitoring Extension
Brief: Maxcyte And Allogene Therapeutics Sign Clinical And Commercial License Agreement To Enable The Advancement Of Allogeneic Car T (Allocar T™) Therapies
Brief: Maxcyte Signs Agreement With KSQ Therapeutics
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Agreement with KSQ Therapeutics